Karim discusses secondary findings from the ELITE trial of timing for estradiol initiation, which reveal a notable impact on Aβ biomarkers of Alzheimer disease.
Roksana Karim, MD, PhD
Advertisement
Articles by Roksana Karim, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Patient Care Online
1
Centanafadine Granted FDA Priority Review for the Treatment of ADHD Across Pediatric and Adult Populations
2
Colorectal Cancer Becomes Leading Cause of Cancer Death in US Adults Younger Than 50 Years, Study Finds
3